Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jun 02,2017
Study Discovers the Key to Youthful Skin
    We have all fallen victim to cluttering our bathroom shelves with an abundance of cosmetic products with the promise of retaining youthful skin, and feeling deflated when none of them actually do. Well, the solution to this on-going issue could finally be upon us.     However now, new data from a team of investigators at UniversityRead more
More
Jun 02,2017
Gene Drive Insect Control May Stall in the Field
    If gene-editing technology is used to suppress insect populations, it may give rise to resistance, mainly through naturally occurring genetic variation and inbreeding among targeted insects. These findings, from a study conducted at Indiana University, suggest that artificially induced genetic modifications are unlikely to spread between regions or species. Such genetic modifications, however, could haveRead more
More
Gene Drive Insect Control May Stall in the Field
Jun 01,2017
Bioequivalence Study of Generic Drugs
FDA has defined bioequivalence as "the absence of a significant difference in the rate and extent to which the active ingredient or active moiety in pharmaceutical equivalents or pharmaceutical alternatives becomes available at the site of drug action when administered at the same molar dose under similar conditions in an appropriately designed study.” The purposeRead more
More
Bioequivalence Study of Generic Drugs
Jun 01,2017
Better Treatment for Kidney Cancer
    Research in the field of kidney cancer, also called renal cancer, is vital, because many patients with this disease still cannot be cured today. Researchers have now identified some of the gene mutations that contribute to the development of carcinomas in the kidneys. They also developed a mouse model that will contribute to progress inRead more
More
Better Treatment for Kidney Cancer
Jun 01,2017
Jamming Signals between Jammed Tumor Cells Disrupts Metastasis
Cancer is a broad term referring to many diseases that are characterized by the development of abnormal cells dividing uncontrollably. These cells can invade and destroy normal tissue, leading to cancer spread and the development of typical cancer-related symptoms. A lot of research is devoted to finding an effective remedy for this affliction. New findingsRead more
More
Jamming Signals between Jammed Tumor Cells Disrupts Metastasis
May 31,2017
Crack in CRISPR Facade after Unanticipated In Vivo Mutations Arise
    The CRISPR/Cas9 genome-editing technique set the molecular biology field ablaze when its game-changing potential was realized only a few short years ago. In the time since this wildfire of excitement and hope, it has spread to almost every life science endeavor imaginable and shows little sign of slowing down. However, new data from a teamRead more
More
Crack in CRISPR Facade after Unanticipated In Vivo Mutations Arise
May 31,2017
Scientists Supercharge Powerful Antibiotic
Scientists at The Scripps Research Institute (TSRI) have tweaked a powerful antibiotic, called vancomycin, so it is once more powerful against life-threatening bacterial infections. Researchers say the more powerful compound could eliminate the threat of antibiotic resistance for many years to come. "Doctors could use this modified form of vancomycin without fear of resistance emerging,”Read more
More
Scientists Supercharge Powerful Antibiotic
May 30,2017
Synthetic Genes Can Reprogram Cells to Perform Targeted Therapy
    University of Washington (UW) synthetic biologists have taken advantage of synthetic biology to turn yeast cells into building blocks for digital information processing. They built a set of synthetic genes that function in cells like NOR gates, commonly used in electronics, which each take two inputs and only pass on a positive signal if both inputsRead more
More
May 30,2017
Parasitic Worm Spit Speeds Wound Recovery
    Researchers claim a molecule found in the spit of a parasitic worm can bolster the healing process for diabetics, the elderly and smokers with lingering wounds.       A team of scientists from the Australian Institute of Tropical Health and Medicine (AITHM) at James Cook University discovered the molecule granulin, found in the saliva of a parasitic liver flukeRead more
More
Parasitic Worm Spit Speeds Wound Recovery
May 26,2017
Blood Test Could Reduces Breast Biopsies Up to 67 Percent
    Noninvasive molecular diagnostic techniques are not only the latest cutting-edge technique to help clinicians improve disease prognosis — they are proving to be an essential element for the continued progression of precision medicine initiatives.     Now, a team of investigators led by scientists at Provista Diagnostics has just released data from a new study demonstrating thatRead more
More
Blood Test Could Reduces Breast Biopsies Up to 67 Percent
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->